injectable ghk-cu All About GHK-Cu Peptide |

Topical application is the most common and well-studied route, particularly for skin and wound healing research

In its ongoing phase 3 clinical trial, a randomized, observer-blind study, which assesses the safety, tolerability, and immunogenicity single dose combination vaccine candidate against influenza and COVID-19 in over 8000 healthy adults 18 to 64 years of age

Improvement of Skin Texture and Tone : Clinical and preclinical data indicate that GHK-Cu can reduce fine lines, wrinkles, and skin roughness through enhanced collagen matrix formation and hydration

There were several limitations of our work, the main one being that this was an in vitro study using human cell lines in 2D cell cultures

Naahidi et al., 2017))